Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 3 1

Status

Unknown 13Recruiting 8Not yet recruiting 4Completed 4Active not recruiting 2

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Non-Small-Cell Lung 128Breast Neoplasms 95Colorectal Neoplasms 62Carcinoma, Hepatocellular 59Stomach Neoplasms 49Squamous Cell Carcinoma of Head and Neck 47Lung Neoplasms 44Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Triple Negative Breast Neoplasms 42Small Cell Lung Carcinoma 40Uterine Cervical Neoplasms 37Rectal Neoplasms 36Pancreatic Neoplasms 31Neoplasms 29Neoplasm Metastasis 29Recurrence 26Esophageal Squamous Cell Carcinoma 25Ovarian Neoplasms 23Esophageal Neoplasms 23Nasopharyngeal Carcinoma 21Brain Neoplasms 21Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Carcinoma, Renal Cell 20Melanoma 19Endometrial Neoplasms 19Biliary Tract Neoplasms 18Head and Neck Neoplasms 17Multiple Myeloma 16

Interventions

tislelizumab 1Oxaliplatin 1Injections 1Immune Checkpoint Inhibitors 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Locally Advanced Rectal Cancer × Clear all
NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Fujian Cancer Hospital

Phase 2 Not yet recruiting
130 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT06760520 2025-01-08

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT06304987 2024-03-19

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Beijing Friendship Hospital

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

NCT05998122 2023-08-18

Total Neoadjuvant Chemoradiotherapy Plus Anti-PD-1 in Subperitoneal Patients With Locally Advanced Rectal CancerPatients With Locally Advanced Rectal Cancer: A Prospective, Single Arm, Exploratory Study

The First Hospital of Jilin University

Phase 2 Not yet recruiting
45 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡